Viola Klück

1.1k total citations
16 papers, 595 citations indexed

About

Viola Klück is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Viola Klück has authored 16 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Nephrology and 5 papers in Immunology. Recurrent topics in Viola Klück's work include Inflammasome and immune disorders (12 papers), Gout, Hyperuricemia, Uric Acid (11 papers) and IL-33, ST2, and ILC Pathways (3 papers). Viola Klück is often cited by papers focused on Inflammasome and immune disorders (12 papers), Gout, Hyperuricemia, Uric Acid (11 papers) and IL-33, ST2, and ILC Pathways (3 papers). Viola Klück collaborates with scholars based in Netherlands, Romania and United States. Viola Klück's co-authors include Leo A. B. Joosten, Tania O. Crișan, Radu A. Popp, Charles A. Dinarello, Maartje C. P. Cleophas, Tim Jansen, Ruiqi Liu, Isak W. Tengesdal, M. Efdé and M. Janssen and has published in prestigious journals such as Journal of Biological Chemistry, Immunological Reviews and Annals of the Rheumatic Diseases.

In The Last Decade

Viola Klück

16 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viola Klück Netherlands 8 369 294 167 88 79 16 595
Farnaz Khalighinejad United States 7 415 1.1× 99 0.3× 194 1.2× 44 0.5× 25 0.3× 14 558
Rojo A. Ratsimandresy United States 10 621 1.7× 105 0.4× 377 2.3× 120 1.4× 26 0.3× 10 757
Rosa Penza Italy 14 160 0.4× 94 0.3× 64 0.4× 43 0.5× 66 0.8× 17 584
John Sterpka United States 7 254 0.7× 186 0.6× 80 0.5× 86 1.0× 119 1.5× 8 551
Sara Bindoli Italy 13 156 0.4× 80 0.3× 126 0.8× 49 0.6× 105 1.3× 29 432
Tung‐Nan Liao Taiwan 14 174 0.5× 103 0.4× 149 0.9× 69 0.8× 27 0.3× 20 601
Hana M. Russo United States 8 612 1.7× 95 0.3× 317 1.9× 143 1.6× 13 0.2× 8 854
Alexander Holderied Germany 7 137 0.4× 164 0.6× 203 1.2× 46 0.5× 10 0.1× 12 442
Isela Valera United States 12 93 0.3× 44 0.1× 192 1.1× 30 0.3× 62 0.8× 24 524
Yuexin Yang China 10 259 0.7× 23 0.1× 98 0.6× 35 0.4× 38 0.5× 20 447

Countries citing papers authored by Viola Klück

Since Specialization
Citations

This map shows the geographic impact of Viola Klück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Klück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Klück more than expected).

Fields of papers citing papers by Viola Klück

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Klück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Klück. The network helps show where Viola Klück may publish in the future.

Co-authorship network of co-authors of Viola Klück

This figure shows the co-authorship network connecting the top 25 collaborators of Viola Klück. A scholar is included among the top collaborators of Viola Klück based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola Klück. Viola Klück is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ea, Hang‐Korng, Brenda Kischkel, Viola Klück, et al.. (2024). Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker. Annals of the Rheumatic Diseases. 83(7). 1–12. 13 indexed citations
2.
Röring, Rutger J., Wenchao Li, Ruiqi Liu, et al.. (2024). Epigenetic, transcriptional, and functional characterization of myeloid cells in familial Mediterranean fever. iScience. 27(4). 109356–109356. 2 indexed citations
3.
Liu, Ruiqi, Viola Klück, Brenda Kischkel, et al.. (2024). Soluble urate-induced effects on cytokine production in vitro – Assessment of methodologies and cell types. Cytokine. 175. 156502–156502. 1 indexed citations
4.
Klück, Viola, Andreea-Manuela Mirea, Anca Bojan, et al.. (2024). Regulation of SOCS3-STAT3 in urate-induced cytokine production in human myeloid cells. Joint Bone Spine. 91(3). 105698–105698. 5 indexed citations
5.
Kischkel, Brenda, Viola Klück, Boris Novakovic, et al.. (2024). Downregulation of type I interferon signalling pathway by urate in primary human PBMCs. Immunology. 174(1). 100–112. 1 indexed citations
6.
Bruno, Mariolina, Rutger J. Röring, Simone J.C.F.M. Moorlag, et al.. (2023). Peripheral T Cell Populations are Differentially Affected in Familial Mediterranean Fever, Chronic Granulomatous Disease, and Gout. Journal of Clinical Immunology. 43(8). 2033–2048. 3 indexed citations
7.
Klück, Viola, Collins K. Boahen, Brenda Kischkel, et al.. (2023). A functional genomics approach reveals suggestive quantitative trait loci associated with combined TLR4 and BCP crystal-induced inflammation and osteoarthritis. Osteoarthritis and Cartilage. 31(8). 1022–1034. 6 indexed citations
8.
Made, Caspar I. van der, Viola Klück, Annet Simons, et al.. (2022). Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study. Cytokine. 162. 156102–156102. 1 indexed citations
9.
Cleophas, Maartje C. P., Viola Klück, Robab Davar, et al.. (2021). Urate-induced epigenetic modifications in myeloid cells. Arthritis Research & Therapy. 23(1). 202–202. 29 indexed citations
10.
Klück, Viola, Ruiqi Liu, & Leo A. B. Joosten. (2020). The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine. 88(2). 105092–105092. 55 indexed citations
11.
Klück, Viola, Tim Jansen, M. Janssen, et al.. (2020). Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. The Lancet Rheumatology. 2(5). e270–e280. 197 indexed citations
12.
Cleophas, Maartje C. P., Tania O. Crișan, Viola Klück, et al.. (2019). Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Research & Therapy. 21(1). 50–50. 37 indexed citations
13.
Klück, Viola, M. Janssen, Tim Jansen, et al.. (2019). P159/O30 OLT1177™, an oral NLRP3 inflammasome inhibitor, inhibits acute joint inflammation and circulating IL 1β during gout flares in humans. Annals of the Rheumatic Diseases. 78. A69–A69. 3 indexed citations
14.
Crișan, Tania O., et al.. (2019). Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia. Immunological Reviews. 294(1). 92–105. 183 indexed citations
15.
Jansen, Tim, Viola Klück, M. Janssen, et al.. (2019). P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout. Annals of the Rheumatic Diseases. 78. A70–A71. 15 indexed citations
16.
Ballak, Dov B., Suzhao Li, Giulio Cavalli, et al.. (2018). Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue. Journal of Biological Chemistry. 293(37). 14224–14236. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farnaz Khalighinejad Breakdown of academic impact, for papers by Rojo A. Ratsimandresy Breakdown of academic impact, for papers by Rosa Penza Breakdown of academic impact, for papers by John Sterpka Breakdown of academic impact, for papers by Sara Bindoli Breakdown of academic impact, for papers by Tung‐Nan Liao Breakdown of academic impact, for papers by Hana M. Russo Breakdown of academic impact, for papers by Alexander Holderied Breakdown of academic impact, for papers by Isela Valera Breakdown of academic impact, for papers by Yuexin Yang
Rankless by CCL
2026